Association of C-reactive protein and insulin resistance in patients with chronic spinal cord injury

Journal of Rehabilitation Medicine

Volumn 40, Issue 10, 2008, Pages 819-822

  Huang, Chun Chiang ^a   Liu, Chin Wei ^b   Weng, Ming Cheng ^a   Chen, Tien Wen ^a   Huang, Mao Hsiung ^b,c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

C reactive protein; Cardiovascular disease; Insulin resistance; Spinal cord injury

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PARAPLEGIA; PROTEIN BLOOD LEVEL; QUADRIPLEGIA; SPINAL CORD INJURY;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PARAPLEGIA; QUADRIPLEGIA; RISK FACTORS; SPINAL CORD INJURIES;

EID: 56749098005     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0264     Document Type: Article

References (29)

1. Nam CC, Odderson IR. Stroke in spinal cord injured. J Am Paraplegia Soc 1994; 17: 36-38.
2. Demirel S, Demirel G, Tukek T, Erk O, Yilmaz H. Risk factors for coronary heart disease in patients with spinal cord injury in Turkey. Spinal Cord 2001; 39: 134-138.
3. Bauman WA, Adkins RH, Spungen AM, Waters RL. The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord 1999; 37: 765-771.
4. Myers J, Lee M, Kiratli J. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 2007; 86: 142-152.
5. Yakuteil M, Brooks ME, Ohry A,Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease, and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 1989; 27: 58-62.
6. Figaro MK, Kritchevsky SB, Shorr RI, Butler J, Shintani A, Penninx BW, et al. Diabetes, inflammation, and functional decline in older adults. Diabetes Care 2006; 29: 2039-2045.
7. Maki KC, Briones ER, Langbein WE, Inman-Felton A, Nemchausky B, Welch M, et al. Associations between serum lipids and indicators of adiposity in men with spinal cord injury. Paraplegia 1995; 33: 102-109.
8. Dallmeiler AJ, Hopman MT, van der Woude LH. Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia. Arch Phys Med Rehabil 1997; 78: 1173-1176.
9. Weaver FM, Collins EG, Kurichi J, Miskevics S, Smith B, Rajan S, et al. Prevalence of obesity and high blood pressure in veterans with spinal cord injuries and disorders: a retrospective review. Am J Phys Med Rehabil 2007; 86: 22-29.
10. Steven ES, Jongsoon L, Allison BG. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
11. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 560-567.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
13. Pradhan AD, Manso JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
14. Koenig W. C-reactive protein and cardiovascular risk: has the time come for screening the general population? Clin Chem 2001; 47: 9-10.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention and the American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
16. Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 2005; 43: 408-416.
17. Paul MR. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003; 108: 81-85.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Tumer RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. American Spinal Injury Association. International standards for neurological classification of spinal cord injury. Chicago: ASIA; 2002.
20. Lee MY, Myers J, Hayes A, Madan S, Froelicher VF, Perkash I, et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Med 2005; 28: 20-25.
21. Samsa GP, Patrick CH, Feussner JR. Long-term survival of traumatic spinal cord injury. Arch Neurol 1993; 50: 909-914.
22. Thomas B, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 2001; 39: 1171-1176.
23. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 2094-2099.
24. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-1006.
25. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
26. Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, et al. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? Eur J Clin Invest 2005; 35: 265-270.
27. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
28. Groah SL, Weitzenkamp D, Sett P, Soni B, Savic G. The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured. Spinal Cord 2001; 39: 310-317.
29. Rebhun J, Madorsky JG, Glovsky MM. Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury. Ann Allergy 1991; 66: 335-338.